38.35 USD
-0.36 (-0.93%)
KEQU gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of KEQU get a neutral evaluation. Nothing too spectacular is happening here. KEQU is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
KEQU had positive earnings in the past year.
KEQU had a positive operating cash flow in the past year.
In multiple years KEQU reported negative net income over the last 5 years.
In multiple years KEQU reported negative operating cash flow during the last 5 years.
1.2 Ratios
With an excellent Return On Assets value of 6.36%, KEQU belongs to the best of the industry, outperforming 85.11% of the companies in the same industry.
Looking at the Return On Equity, with a value of 18.34%, KEQU belongs to the top of the industry, outperforming 93.09% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 10.92%, KEQU belongs to the top of the industry, outperforming 90.96% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for KEQU is in line with the industry average of 8.71%.
The last Return On Invested Capital (10.92%) for KEQU is above the 3 year average (9.90%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROIC | 10.92% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 4.68%, KEQU is doing good in the industry, outperforming 75.53% of the companies in the same industry.
KEQU has a better Operating Margin (7.60%) than 74.47% of its industry peers.
KEQU has a worse Gross Margin (29.37%) than 76.06% of its industry peers.
KEQU's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KEQU is creating some value.
Compared to 1 year ago, KEQU has about the same amount of shares outstanding.
Compared to 5 years ago, KEQU has more shares outstanding
KEQU has a worse debt/assets ratio than last year.
2.2 Solvency
KEQU has an Altman-Z score of 3.09. This indicates that KEQU is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.09, KEQU is doing good in the industry, outperforming 69.68% of the companies in the same industry.
KEQU has a debt to FCF ratio of 3.45. This is a good value and a sign of high solvency as KEQU would need 3.45 years to pay back of all of its debts.
The Debt to FCF ratio of KEQU (3.45) is better than 82.98% of its industry peers.
A Debt/Equity ratio of 0.91 indicates that KEQU is somewhat dependend on debt financing.
The Debt to Equity ratio of KEQU (0.91) is worse than 73.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Altman-Z | 3.09 |
ROIC/WACC1.42
WACC7.67%
2.3 Liquidity
A Current Ratio of 2.32 indicates that KEQU has no problem at all paying its short term obligations.
KEQU has a Current ratio (2.32) which is comparable to the rest of the industry.
A Quick Ratio of 1.63 indicates that KEQU should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.63, KEQU is in line with its industry, outperforming 43.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 |
3. Growth
3.1 Past
KEQU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.65%.
KEQU shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.09%.
The Revenue has been growing by 10.27% on average over the past years. This is quite good.
EPS 1Y (TTM)-33.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.24%
Revenue 1Y (TTM)30.09%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.92%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.26, the valuation of KEQU can be described as very reasonable.
KEQU's Price/Earnings ratio is rather cheap when compared to the industry. KEQU is cheaper than 94.68% of the companies in the same industry.
KEQU is valuated cheaply when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.26 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, KEQU is valued cheaper than 97.34% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 99.47% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.88 | ||
| EV/EBITDA | 6.07 |
4.3 Compensation for Growth
The decent profitability rating of KEQU may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
KEQU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:KEQU (11/26/2025, 8:00:02 PM)
38.35
-0.36 (-0.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners40.11%
Inst Owner Change1.59%
Ins Owners16.53%
Ins Owner Change0.44%
Market Cap110.06M
Revenue(TTM)263.18M
Net Income(TTM)12.30M
Analysts82.86
Price TargetN/A
Short Float %0.76%
Short Ratio1.19
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.26 | ||
| Fwd PE | N/A | ||
| P/S | 0.42 | ||
| P/FCF | 5.88 | ||
| P/OCF | 5.15 | ||
| P/B | 1.64 | ||
| P/tB | 2.96 | ||
| EV/EBITDA | 6.07 |
EPS(TTM)4.14
EY10.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.52
FCFY17%
OCF(TTM)7.45
OCFY19.41%
SpS91.7
BVpS23.37
TBVpS12.94
PEG (NY)N/A
PEG (5Y)N/A
Graham Number46.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROCE | 13.98% | ||
| ROIC | 10.92% | ||
| ROICexc | 12.63% | ||
| ROICexgc | 16.65% | ||
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% | ||
| FCFM | 7.11% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Debt/EBITDA | 2.38 | ||
| Cap/Depr | 48.41% | ||
| Cap/Sales | 1.01% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.84% | ||
| Profit Quality | 152.04% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 | ||
| Altman-Z | 3.09 |
F-Score4
WACC7.67%
ROIC/WACC1.42
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.09%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y496.38%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y2996.81%
OCF growth 3YN/A
OCF growth 5Y28.86%
KEWAUNEE SCIENTIFIC CP / KEQU FAQ
What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?
ChartMill assigns a fundamental rating of 5 / 10 to KEQU.
Can you provide the valuation status for KEWAUNEE SCIENTIFIC CP?
ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.
How profitable is KEWAUNEE SCIENTIFIC CP (KEQU) stock?
KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.
Can you provide the dividend sustainability for KEQU stock?
The dividend rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 0 / 10 and the dividend payout ratio is 0%.